1 Oral COVID-19 Drug Market Overview 1.1 Product Overview and Scope of Oral COVID-19 Drug 1.2 Oral COVID-19 Drug Segment by Type 1.2.1 Global Oral COVID-19 Drug Market Value Comparison by Type (2023-2029) 1.2.2 Tablet 1.2.3 Capsule 1.3 Oral COVID-19 Drug Segment by Application 1.3.1 Global Oral COVID-19 Drug Market Value by Application: (2023-2029) 1.3.2 Hospital 1.3.3 Clinics 1.4 Global Oral COVID-19 Drug Market Size Estimates and Forecasts 1.4.1 Global Oral COVID-19 Drug Revenue 2018-2029 1.4.2 Global Oral COVID-19 Drug Sales 2018-2029 1.4.3 Global Oral COVID-19 Drug Market Average Price (2018-2029) 1.5 Assumptions and Limitations 2 Oral COVID-19 Drug Market Competition by Manufacturers 2.1 Global Oral COVID-19 Drug Sales Market Share by Manufacturers (2018-2023) 2.2 Global Oral COVID-19 Drug Revenue Market Share by Manufacturers (2018-2023) 2.3 Global Oral COVID-19 Drug Average Price by Manufacturers (2018-2023) 2.4 Global Oral COVID-19 Drug Industry Ranking 2021 VS 2022 VS 2023 2.5 Global Key Manufacturers of Oral COVID-19 Drug, Manufacturing Sites & Headquarters 2.6 Global Key Manufacturers of Oral COVID-19 Drug, Product Type & Application 2.7 Oral COVID-19 Drug Market Competitive Situation and Trends 2.7.1 Oral COVID-19 Drug Market Concentration Rate 2.7.2 The Global Top 5 and Top 10 Largest Oral COVID-19 Drug Players Market Share by Revenue 2.7.3 Global Oral COVID-19 Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Oral COVID-19 Drug Retrospective Market Scenario by Region 3.1 Global Oral COVID-19 Drug Market Size by Region: 2018 Versus 2022 Versus 2029 3.2 Global Oral COVID-19 Drug Global Oral COVID-19 Drug Sales by Region: 2018-2029 3.2.1 Global Oral COVID-19 Drug Sales by Region: 2018-2023 3.2.2 Global Oral COVID-19 Drug Sales by Region: 2024-2029 3.3 Global Oral COVID-19 Drug Global Oral COVID-19 Drug Revenue by Region: 2018-2029 3.3.1 Global Oral COVID-19 Drug Revenue by Region: 2018-2023 3.3.2 Global Oral COVID-19 Drug Revenue by Region: 2024-2029 3.4 North America Oral COVID-19 Drug Market Facts & Figures by Country 3.4.1 North America Oral COVID-19 Drug Market Size by Country: 2018 VS 2022 VS 2029 3.4.2 North America Oral COVID-19 Drug Sales by Country (2018-2029) 3.4.3 North America Oral COVID-19 Drug Revenue by Country (2018-2029) 3.4.4 U.S. 3.4.5 Canada 3.5 Europe Oral COVID-19 Drug Market Facts & Figures by Country 3.5.1 Europe Oral COVID-19 Drug Market Size by Country: 2018 VS 2022 VS 2029 3.5.2 Europe Oral COVID-19 Drug Sales by Country (2018-2029) 3.5.3 Europe Oral COVID-19 Drug Revenue by Country (2018-2029) 3.5.4 Germany 3.5.5 France 3.5.6 U.K. 3.5.7 Italy 3.5.8 Russia 3.6 Asia Pacific Oral COVID-19 Drug Market Facts & Figures by Country 3.6.1 Asia Pacific Oral COVID-19 Drug Market Size by Country: 2018 VS 2022 VS 2029 3.6.2 Asia Pacific Oral COVID-19 Drug Sales by Country (2018-2029) 3.6.3 Asia Pacific Oral COVID-19 Drug Revenue by Country (2018-2029) 3.6.4 China 3.6.5 Japan 3.6.6 South Korea 3.6.7 India 3.6.8 Australia 3.6.9 Taiwan 3.6.10 Indonesia 3.6.11 Thailand 3.6.12 Malaysia 3.6.13 Philippines 3.7 Latin America Oral COVID-19 Drug Market Facts & Figures by Country 3.7.1 Latin America Oral COVID-19 Drug Market Size by Country: 2018 VS 2022 VS 2029 3.7.2 Latin America Oral COVID-19 Drug Sales by Country (2018-2029) 3.7.3 Latin America Oral COVID-19 Drug Revenue by Country (2018-2029) 3.7.4 Mexico 3.7.5 Brazil 3.7.6 Argentina 3.8 Middle East and Africa Oral COVID-19 Drug Market Facts & Figures by Country 3.8.1 Middle East and Africa Oral COVID-19 Drug Market Size by Country: 2018 VS 2022 VS 2029 3.8.2 Middle East and Africa Oral COVID-19 Drug Sales by Country (2018-2029) 3.8.3 Middle East and Africa Oral COVID-19 Drug Revenue by Country (2018-2029) 3.8.4 Turkey 3.8.5 Saudi Arabia 3.8.6 U.A.E 4 Segment by Type 4.1 Global Oral COVID-19 Drug Sales by Type (2018-2029) 4.1.1 Global Oral COVID-19 Drug Sales by Type (2018-2023) 4.1.2 Global Oral COVID-19 Drug Sales by Type (2024-2029) 4.1.3 Global Oral COVID-19 Drug Sales Market Share by Type (2018-2029) 4.2 Global Oral COVID-19 Drug Revenue by Type (2018-2029) 4.2.1 Global Oral COVID-19 Drug Revenue by Type (2018-2023) 4.2.2 Global Oral COVID-19 Drug Revenue by Type (2024-2029) 4.2.3 Global Oral COVID-19 Drug Revenue Market Share by Type (2018-2029) 4.3 Global Oral COVID-19 Drug Price by Type (2018-2029) 5 Segment by Application 5.1 Global Oral COVID-19 Drug Sales by Application (2018-2029) 5.1.1 Global Oral COVID-19 Drug Sales by Application (2018-2023) 5.1.2 Global Oral COVID-19 Drug Sales by Application (2024-2029) 5.1.3 Global Oral COVID-19 Drug Sales Market Share by Application (2018-2029) 5.2 Global Oral COVID-19 Drug Revenue by Application (2018-2029) 5.2.1 Global Oral COVID-19 Drug Revenue by Application (2018-2023) 5.2.2 Global Oral COVID-19 Drug Revenue by Application (2024-2029) 5.2.3 Global Oral COVID-19 Drug Revenue Market Share by Application (2018-2029) 5.3 Global Oral COVID-19 Drug Price by Application (2018-2029) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer Oral COVID-19 Drug Sales, Revenue and Gross Margin (2018-2023) 6.1.4 Pfizer Oral COVID-19 Drug Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 MSD and Ridgeback 6.2.1 MSD and Ridgeback Corporation Information 6.2.2 MSD and Ridgeback Description and Business Overview 6.2.3 MSD and Ridgeback Oral COVID-19 Drug Sales, Revenue and Gross Margin (2018-2023) 6.2.4 MSD and Ridgeback Oral COVID-19 Drug Product Portfolio 6.2.5 MSD and Ridgeback Recent Developments/Updates 6.3 Shionogi 6.3.1 Shionogi Corporation Information 6.3.2 Shionogi Description and Business Overview 6.3.3 Shionogi Oral COVID-19 Drug Sales, Revenue and Gross Margin (2018-2023) 6.3.4 Shionogi Oral COVID-19 Drug Product Portfolio 6.3.5 Shionogi Recent Developments/Updates 7 Industry Chain and Sales Channels Analysis 7.1 Oral COVID-19 Drug Industry Chain Analysis 7.2 Oral COVID-19 Drug Key Raw Materials 7.2.1 Key Raw Materials 7.2.2 Raw Materials Key Suppliers 7.3 Oral COVID-19 Drug Production Mode & Process 7.4 Oral COVID-19 Drug Sales and Marketing 7.4.1 Oral COVID-19 Drug Sales Channels 7.4.2 Oral COVID-19 Drug Distributors 7.5 Oral COVID-19 Drug Customers 8 Oral COVID-19 Drug Market Dynamics 8.1 Oral COVID-19 Drug Industry Trends 8.2 Oral COVID-19 Drug Market Drivers 8.3 Oral COVID-19 Drug Market Challenges 8.4 Oral COVID-19 Drug Market Restraints 9 Research Finding and Conclusion 10 Methodology and Data Source 10.1 Methodology/Research Approach 10.1.1 Research Programs/Design 10.1.2 Market Size Estimation 10.1.3 Market Breakdown and Data Triangulation 10.2 Data Source 10.2.1 Secondary Sources 10.2.2 Primary Sources 10.3 Author List 10.4 Disclaimer

List of Tables Table 1. Global Oral COVID-19 Drug Market Value Comparison by Type (2023-2029) & (US$ Million) Table 2. Global Oral COVID-19 Drug Market Value Comparison by Application (2023-2029) & (US$ Million) Table 3. Global Oral COVID-19 Drug Market Competitive Situation by Manufacturers in 2022 Table 4. Global Oral COVID-19 Drug Sales (K Units) of Key Manufacturers (2018-2023) Table 5. Global Oral COVID-19 Drug Sales Market Share by Manufacturers (2018-2023) Table 6. Global Oral COVID-19 Drug Revenue (US$ Million) by Manufacturers (2018-2023) Table 7. Global Oral COVID-19 Drug Revenue Share by Manufacturers (2018-2023) Table 8. Global Market Oral COVID-19 Drug Average Price (US$/Unit) of Key Manufacturers (2018-2023) Table 9. Global Key Players of Oral COVID-19 Drug, Industry Ranking, 2021 VS 2022 VS 2023 Table 10. Global Key Manufacturers of Oral COVID-19 Drug, Manufacturing Sites & Headquarters Table 11. Global Key Manufacturers of Oral COVID-19 Drug, Product Type & Application Table 12. Global Key Manufacturers of Oral COVID-19 Drug, Date of Enter into This Industry Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Oral COVID-19 Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral COVID-19 Drug as of 2022) Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans Table 16. Global Oral COVID-19 Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 17. Global Oral COVID-19 Drug Sales by Region (2018-2023) & (K Units) Table 18. Global Oral COVID-19 Drug Sales Market Share by Region (2018-2023) Table 19. Global Oral COVID-19 Drug Sales by Region (2024-2029) & (K Units) Table 20. Global Oral COVID-19 Drug Sales Market Share by Region (2024-2029) Table 21. Global Oral COVID-19 Drug Revenue by Region (2018-2023) & (US$ Million) Table 22. Global Oral COVID-19 Drug Revenue Market Share by Region (2018-2023) Table 23. Global Oral COVID-19 Drug Revenue by Region (2024-2029) & (US$ Million) Table 24. Global Oral COVID-19 Drug Revenue Market Share by Region (2024-2029) Table 25. North America Oral COVID-19 Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 26. North America Oral COVID-19 Drug Sales by Country (2018-2023) & (K Units) Table 27. North America Oral COVID-19 Drug Sales by Country (2024-2029) & (K Units) Table 28. North America Oral COVID-19 Drug Revenue by Country (2018-2023) & (US$ Million) Table 29. North America Oral COVID-19 Drug Revenue by Country (2024-2029) & (US$ Million) Table 30. Europe Oral COVID-19 Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 31. Europe Oral COVID-19 Drug Sales by Country (2018-2023) & (K Units) Table 32. Europe Oral COVID-19 Drug Sales by Country (2024-2029) & (K Units) Table 33. Europe Oral COVID-19 Drug Revenue by Country (2018-2023) & (US$ Million) Table 34. Europe Oral COVID-19 Drug Revenue by Country (2024-2029) & (US$ Million) Table 35. Asia Pacific Oral COVID-19 Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million) Table 36. Asia Pacific Oral COVID-19 Drug Sales by Region (2018-2023) & (K Units) Table 37. Asia Pacific Oral COVID-19 Drug Sales by Region (2024-2029) & (K Units) Table 38. Asia Pacific Oral COVID-19 Drug Revenue by Region (2018-2023) & (US$ Million) Table 39. Asia Pacific Oral COVID-19 Drug Revenue by Region (2024-2029) & (US$ Million) Table 40. Latin America Oral COVID-19 Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 41. Latin America Oral COVID-19 Drug Sales by Country (2018-2023) & (K Units) Table 42. Latin America Oral COVID-19 Drug Sales by Country (2024-2029) & (K Units) Table 43. Latin America Oral COVID-19 Drug Revenue by Country (2018-2023) & (US$ Million) Table 44. Latin America Oral COVID-19 Drug Revenue by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Oral COVID-19 Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 46. Middle East & Africa Oral COVID-19 Drug Sales by Country (2018-2023) & (K Units) Table 47. Middle East & Africa Oral COVID-19 Drug Sales by Country (2024-2029) & (K Units) Table 48. Middle East & Africa Oral COVID-19 Drug Revenue by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Oral COVID-19 Drug Revenue by Country (2024-2029) & (US$ Million) Table 50. Global Oral COVID-19 Drug Sales (K Units) by Type (2018-2023) Table 51. Global Oral COVID-19 Drug Sales (K Units) by Type (2024-2029) Table 52. Global Oral COVID-19 Drug Sales Market Share by Type (2018-2023) Table 53. Global Oral COVID-19 Drug Sales Market Share by Type (2024-2029) Table 54. Global Oral COVID-19 Drug Revenue (US$ Million) by Type (2018-2023) Table 55. Global Oral COVID-19 Drug Revenue (US$ Million) by Type (2024-2029) Table 56. Global Oral COVID-19 Drug Revenue Market Share by Type (2018-2023) Table 57. Global Oral COVID-19 Drug Revenue Market Share by Type (2024-2029) Table 58. Global Oral COVID-19 Drug Price (US$/Unit) by Type (2018-2023) Table 59. Global Oral COVID-19 Drug Price (US$/Unit) by Type (2024-2029) Table 60. Global Oral COVID-19 Drug Sales (K Units) by Application (2018-2023) Table 61. Global Oral COVID-19 Drug Sales (K Units) by Application (2024-2029) Table 62. Global Oral COVID-19 Drug Sales Market Share by Application (2018-2023) Table 63. Global Oral COVID-19 Drug Sales Market Share by Application (2024-2029) Table 64. Global Oral COVID-19 Drug Revenue (US$ Million) by Application (2018-2023) Table 65. Global Oral COVID-19 Drug Revenue (US$ Million) by Application (2024-2029) Table 66. Global Oral COVID-19 Drug Revenue Market Share by Application (2018-2023) Table 67. Global Oral COVID-19 Drug Revenue Market Share by Application (2024-2029) Table 68. Global Oral COVID-19 Drug Price (US$/Unit) by Application (2018-2023) Table 69. Global Oral COVID-19 Drug Price (US$/Unit) by Application (2024-2029) Table 70. Pfizer Corporation Information Table 71. Pfizer Description and Business Overview Table 72. Pfizer Oral COVID-19 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 73. Pfizer Oral COVID-19 Drug Product Table 74. Pfizer Recent Developments/Updates Table 75. MSD and Ridgeback Corporation Information Table 76. MSD and Ridgeback Description and Business Overview Table 77. MSD and Ridgeback Oral COVID-19 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 78. MSD and Ridgeback Oral COVID-19 Drug Product Table 79. MSD and Ridgeback Recent Developments/Updates Table 80. Shionogi Corporation Information Table 81. Shionogi Description and Business Overview Table 82. Shionogi Oral COVID-19 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 83. Shionogi Oral COVID-19 Drug Product Table 84. Shionogi Recent Developments/Updates Table 85. Key Raw Materials Lists Table 86. Raw Materials Key Suppliers Lists Table 87. Oral COVID-19 Drug Distributors List Table 88. Oral COVID-19 Drug Customers List Table 89. Oral COVID-19 Drug Market Trends Table 90. Oral COVID-19 Drug Market Drivers Table 91. Oral COVID-19 Drug Market Challenges Table 92. Oral COVID-19 Drug Market Restraints Table 93. Research Programs/Design for This Report Table 94. Key Data Information from Secondary Sources Table 95. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Oral COVID-19 Drug Figure 2. Global Oral COVID-19 Drug Market Value Comparison by Type (2023-2029) & (US$ Million) Figure 3. Global Oral COVID-19 Drug Market Share by Type in 2022 & 2029 Figure 4. Tablet Product Picture Figure 5. Capsule Product Picture Figure 6. Global Oral COVID-19 Drug Market Value Comparison by Application (2023-2029) & (US$ Million) Figure 7. Global Oral COVID-19 Drug Market Share by Application in 2022 & 2029 Figure 8. Hospital Figure 9. Clinics Figure 10. Global Oral COVID-19 Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029 Figure 11. Global Oral COVID-19 Drug Market Size (2018-2029) & (US$ Million) Figure 12. Global Oral COVID-19 Drug Sales (2018-2029) & (K Units) Figure 13. Global Oral COVID-19 Drug Average Price (US$/Unit) & (2018-2029) Figure 14. Oral COVID-19 Drug Report Years Considered Figure 15. Oral COVID-19 Drug Sales Share by Manufacturers in 2022 Figure 16. Global Oral COVID-19 Drug Revenue Share by Manufacturers in 2022 Figure 17. The Global 5 and 10 Largest Oral COVID-19 Drug Players: Market Share by Revenue in 2022 Figure 18. Oral COVID-19 Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022 Figure 19. Global Oral COVID-19 Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Figure 20. North America Oral COVID-19 Drug Sales Market Share by Country (2018-2029) Figure 21. North America Oral COVID-19 Drug Revenue Market Share by Country (2018-2029) Figure 22. U.S. Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 23. Canada Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 24. Europe Oral COVID-19 Drug Sales Market Share by Country (2018-2029) Figure 25. Europe Oral COVID-19 Drug Revenue Market Share by Country (2018-2029) Figure 26. Germany Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 27. France Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 28. U.K. Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 29. Italy Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 30. Russia Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 31. Asia Pacific Oral COVID-19 Drug Sales Market Share by Region (2018-2029) Figure 32. Asia Pacific Oral COVID-19 Drug Revenue Market Share by Region (2018-2029) Figure 33. China Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 34. Japan Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 35. South Korea Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 36. India Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 37. Australia Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 38. Taiwan Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 39. Indonesia Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 40. Thailand Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 41. Malaysia Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 42. Philippines Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 43. Latin America Oral COVID-19 Drug Sales Market Share by Country (2018-2029) Figure 44. Latin America Oral COVID-19 Drug Revenue Market Share by Country (2018-2029) Figure 45. Mexico Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 46. Brazil Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 47. Argentina Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 48. Middle East & Africa Oral COVID-19 Drug Sales Market Share by Country (2018-2029) Figure 49. Middle East & Africa Oral COVID-19 Drug Revenue Market Share by Country (2018-2029) Figure 50. Turkey Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 51. Saudi Arabia Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 52. U.A.E Oral COVID-19 Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 53. Global Sales Market Share of Oral COVID-19 Drug by Type (2018-2029) Figure 54. Global Revenue Market Share of Oral COVID-19 Drug by Type (2018-2029) Figure 55. Global Oral COVID-19 Drug Price (US$/Unit) by Type (2018-2029) Figure 56. Global Sales Market Share of Oral COVID-19 Drug by Application (2018-2029) Figure 57. Global Revenue Market Share of Oral COVID-19 Drug by Application (2018-2029) Figure 58. Global Oral COVID-19 Drug Price (US$/Unit) by Application (2018-2029) Figure 59. Oral COVID-19 Drug Value Chain Figure 60. Oral COVID-19 Drug Production Process Figure 61. Channels of Distribution (Direct Vs Distribution) Figure 62. Distributors Profiles Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

Pfizer MSD and Ridgeback Shionogi